Article ID Journal Published Year Pages File Type
8712485 Dermatologica Sinica 2017 5 Pages PDF
Abstract
Omalizumab is an effective and safe treatment for antihistamine refractory CSU. Maintenance therapy with individual tailoring of the treatment duration and interval is possible.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Dermatology
Preview
Efficacy of omalizumab treatment for patients with chronic idiopathic urticaria (CIU)/chronic spontaneous urticaria (CSU) in Taiwan
Authors
, , ,